Pharmally International Holding Company Limited Sustainability Profile
Pharmally International Holding Company Limited, often referred to simply as Pharmally, is a prominent player in the pharmaceutical and healthcare industry, headquartered in Taiwan (TW). Founded in 2015, the company has rapidly expanded its operations across various regions, focusing on the production and distribution of high-quality medical supplies and pharmaceuticals. Pharmally's core offerings include essential medical equipment, personal protective equipment (PPE), and innovative healthcare solutions, distinguished by their commitment to quality and compliance with international standards. The company has achieved significant milestones, positioning itself as a trusted supplier during critical times, particularly in response to global health challenges. With a strong market presence and a reputation for reliability, Pharmally continues to enhance its product portfolio, striving to meet the evolving needs of healthcare providers worldwide.
DitchCarbon Score
How does Pharmally International Holding Company Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pharmally International Holding Company Limited's score of 20 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pharmally International Holding Company Limited's reported carbon emissions
Pharmally International Holding Company Limited, headquartered in Taiwan (TW), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate commitments, including those aligned with the Science Based Targets initiative (SBTi) or other industry standards. As a result, Pharmally's climate strategy remains unclear, and there are no inherited emissions data from a parent or related organization. The company has not publicly committed to any climate pledges or initiatives aimed at reducing its carbon footprint. Without available data or commitments, it is challenging to assess Pharmally's position within the broader context of corporate climate responsibility.
How Carbon Intensive is Pharmally International Holding Company Limited's Industry?
How Carbon Intensive is Pharmally International Holding Company Limited's Location?
Pharmally International Holding Company Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pharmally International Holding Company Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
